Crossmark

Effects of omega-3 fatty acids on metabolic syndrome in patients with schizophrenia: a 12-week randomized placebo-controlled trial

Crossref DOI link: https://doi.org/10.1007/s00213-018-5136-9

Published Online: 2018-12-05

Published Print: 2019-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xu, Feikang

Fan, Weixing

Wang, Weiping

Tang, Wei

Yang, Fuyin

Zhang, Yi

Cai, Jun

Song, Lisheng

Zhang, Chen http://orcid.org/0000-0003-4071-1627
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81771450, 81471358)

Shanghai Science and Technology Commission Foundation (14411969000)

Shanghai Municipal Education Commission—Gaofeng Clinical Medicine Grant Support (20152530)

Shanghai Municipal Commission of Health and Family Planning Foundation (201540029)

Shanghai Municipal Commission of Health and Family Planning, Key Developing Disciplines (2015ZB0405)
License Information

Text and Data Mining valid from 2018-12-05
More Information

Article History

Received: 13 August 2018

Accepted: 22 November 2018

First Online: 5 December 2018

Compliance with ethical standards

: All procedures for this study were reviewed and approved by the Institutional Review Boards of the Shanghai Mental Health Center and other participating institutions. This study was performed in strict accordance with the Declaration of Helsinki and other relevant national and international regulations.

: The authors declare that they have no conflict of interest.